Cervical cancer rates and deaths are increasing around the world, with the highest rates in sub-Saharan Africa.

Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy cells.

New research identifies molecular signatures in SCLC that could improve immunotherapy outcome prediction beyond conventional staging.

A 12-year study of more than 52,000 women finds no increased cardiovascular risk with modern hormone replacement therapy started during midlife.

The study followed 4,190 adults with stage 2 hypertension in Pakistan for 12 months, who had their blood pressure continuously monitored using a wrist-worn fitness tracker.

A circular RNA (circRNA) drug enhanced saliva production in radiation-induced xerostomia, a promising development in the ...

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

Measuring cell-free DNA in blood could help oncologists assess how well CAR T-cell therapy is working for treatment of blood ...

A soft robot could perform real-time imaging, deliver drugs, and take biopsies within the hard-to-reach small intestine.